招财日报2024.12.5 Salesforce及三生制药公司点评

招银国际
05 Dec 2024

公司点评Salesforce(CRM US,买入,目标价410.0美元)- 3QFY25业绩符合预期;Agentforce成为主要催化Salesforce公布了符合预期的3QFY25业绩:总收入同比增长8%至94.4亿美元,非GAAP净利润同比增长12%至23.2亿美元,均符合一致预期。3QFY25 cRPO同比增长10%,好于此前预期(同比增长9%),主要得益于部分客户提前续订、良好的新签订单...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10